Accepted for/Published in: JMIR Formative Research
Date Submitted: Apr 16, 2024
Open Peer Review Period: Apr 19, 2024 - Jun 14, 2024
Date Accepted: Nov 28, 2024
Date Submitted to PubMed: Nov 29, 2024
(closed for review but you can still tweet)
Effectiveness of a Video-Conference Cognitive Behavioral Therapy for Patients with Schizophrenia: A Pilot Randomized Controlled Trial
ABSTRACT
Background:
Cognitive behavioral therapy for psychosis (CBTp) is not widespread enough in clinical practice, although evidence has been presented.
Objective:
The purpose of this study was to determine whether cognitive behavioral therapy for psychosis using video-conferencing (vCBTp) was more effective than usual care (UC) treatment alone in improving psychiatric symptoms in patients with schizophrenia attending outpatient clinics.
Methods:
In this exploratory randomized controlled trial, patients with schizophrenia and schizoaffective disorders who were still taking medication in an outpatient clinic were randomly assigned to either the UC plus vCBTp group (n=12) or the UC group (n=12). The vCBTp was conducted once a week, with each section lasting for 50 min, for a total of seven sessions in real-time. The primary outcome was the Positive and Negative Syndrome Scale (PANSS) total score, which measures the difference in the mean change from baseline at week 0 to post-test at week 8.
Results:
Concerning the significant difference in the primary endpoint between the two groups, the mean change from baseline in the PANSS total score at week 8 in the vCBTp plus UC group (-9.5) was significantly greater (P<.001) than the mean change in the UC alone group (6.9). In addition, significant improvements were observed in positive symptoms, negative symptoms, and overall psychopathology subscales. No participants dropped out of the study, and no serious adverse events occurred.
Conclusions:
Summarily, all seven vCBTp sessions were effective in improving psychiatric symptoms. This approach is expected to improve the acceptance and accessibility of CBTp among outpatients with schizophrenia, potentially contributing to relapse prevention support and stepped care. Clinical Trial: University Hospital Medical Information Network Clinical Trials Registry: UMIN000043396; https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000049544
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.